The putative tumor suppressor gene GLTSCR2 induces PTEN-modulated cell death

Cell Death and Differentiation

Volumn 14, Issue 11, 2007, Pages 1872-1879

  Yim, J H ^a   Kim, Y J ^a   Ko, J H ^a   Cho, Y E ^a   Kim, S M ^a   Kim, J Y ^a   Lee, S ^a   Park, J H ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL NUCLEUS; CONTROLLED STUDY; CYTOTOXICITY; GENE OVEREXPRESSION; GLIOBLASTOMA; GLIOMA TUMOR SUPPRESSOR CANDIDATE REGION GENE 2; HUMAN; HUMAN CELL; MITOCHONDRION; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

APOPTOSIS; CELL LINE; CELL NUCLEUS; GENES, TUMOR SUPPRESSOR; HUMANS; NUCLEAR PROTEINS; PHOSPHORYLATION; PTEN PHOSPHOHYDROLASE; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEINS;

EID: 35548960064     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4402204     Document Type: Article

References (22)

1. Smith JS, Tachibana I, Pohl U, Lee HK, Thanarajasingam U, Portier BP et al. A transcript map of the chromosome 19q-arm glioma tumor suppressor region. Genomics 2000; 64: 44-50.
2. Trent JM, Kaneko Y, Mitelman F. Report of the committee on structural chromosome changes in neoplasia. Cytogenet Cell Genet 1989; 51 533-562.
3. Rosenberg JE, Lisle DK, Burwick JA, Ueld K, von Deimling A, Mohrenweiser HW et al. Refined deletion mapping of the chromosome 19q glioma tumor suppressor gane to the D19S412-STD interval. Oncogene 1996; 13: 2483-2485.
4. Ritland SR, Ganju V, Jenkins RB, Region-specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma. Genes Chromosomes Cancer 1995; 12: 277-282.
5. Rubio MP, Correa KM, Uaki K, Mohrenweiser HW, Gusella JF, von Deimling A et al. The putative glioma tumor suppressor gone on chromosome 19q map between APOC2 and HRC. Cancer Res 1994; 54: 4760-4763.
6. Bruni R, Fineschi B, Ogle WO, Roizman B. A novel cellular protein, p60, interacting with both herpes simplex virus 1 regulatory proteins ICP22 and ICP0 is modified in a cell-type-specific manner and is recruited to the nucleus after infection. J Virol 1999; 73: 3810-3817.
7. Okharaa F, Ikawa H, Kanaho Y, Maehama T. Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein. J Biol Chem 2004; 279: 45300-45303.
8. Okahara F, Itoh K, Nakagawara A, Murakami M, Kanaho Y, Maehama T. Critical role of PICT-1, a tumor suppressor candidate, in phosphatidylinositol 3,4,5-trisphosphate signals and tumorigenic transformation. Mol Biol Cell 2006; 17: 4888-4895.
9. Myers MP, Stolarov JP, Eng C, Li J, Wang SI, Wigler MH et al. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci USA 1997; 94 9052-9057.
10. Gu J, Tamura M, Yamada KM. Tumor suppressor PTEN inhibits integrin-and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways. J Cell Biol 1998; 143: 1375-1383.
11. Maehama T, Dixon JE. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 1998; 273: 13375-13378.
12. Leslie NR, Downes CP. PTEN: The down side of PI 3-kinase signalllng. Cell Signal 2003; 14: 285-295.
13. Downward J. PI 3-kinase, Akt and cell survival. Semin Cell Dev Biol 2004; 15: 177-182.
14. Adachi J, Ohbayashi K, Suzuki T, Sasaki T. Cell cycle arrest and astrocytic differentiation resulting from PTEN expression in glioma cells. J Neurosurg 1999; 91: 822-830.
15. Maier D, Jones G, Li X, Schonthal AH, Gratzl O, Van Meir EG et al. The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells. Cancer Res 1999; 59: 5479-5482.
16. Park MJ, Kim MS, Park IC, Kang HS, Yoo H, Park SH et al. PTEN suppressa hyaluronic, acid-inducad matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation. Cancer Res 2002; 62:6318-6322.
17. Wu ZX, Song TB, U DM, Zhang XT, Wu XL. Overexpression of PTEN suppresses growth and induces apoptosis by inhibiting the expression of survivin in bladder cancer cells. Tumour Biol 2006; 26: 9-15.
18. Zhou M, Gu L, Findley HW, Jiang R, Woods WG. PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells. Cancer Res 2003; 63: 6357-6362.
19. Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG, Youle RJ. Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol 1997; 139: 1281-1292.
20. Ray R, Chen G, Vande Velde C, Cizeau J, Park JH, Reed JC et al. BNIP3 heterodimerizes with Bcl-2/Bcl-X(L)and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial ano nonmitochondrial sites. J Biol Chem 2000; 275: 1439-1448.
21. Zhu Y, Hoell P, Ahlemeyer B, Krieglstein J. PTEN.a crucial mediator of mitochondria-dependent apoptosis. Apoptosis 2006; 11: 197-207.
22. Kim J, Ahn H, Ryu J, Suk K, Park J. BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha. J Exp Med 2004; 199: 113-124.